Inconsistently, while Martin-Maestro et al. showed enhanced PINK1, Parkin, and TOMM20 expressions [51], Ye et al. noticed a reduced cytosolic and increased mitochondrial Parkin levels in AD brains [86]. This evidence concerns the gene PRKN and Alzheimer disease.